Viking Therapeutics Inc (NASDAQ:VKTX) price on current trading day, rose 2.07% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $30.07.
A look at the stock’s price movement, the close in the last trading session was $29.46, moving within a range at $29.03 and $30.17. The beta value (5-Year monthly) was 0.897. Turning to its 52-week performance, $89.10 and $24.41 were the 52-week high and 52-week low respectively. Overall, VKTX moved 2.77% over the past month.
Viking Therapeutics Inc’s market cap currently stands at around $3.38 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-04.
Turning to the stock’s technical picture we see that short term indicators suggest on average that VKTX is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
7 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 6 recommend VKTX as a Buy and 1 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
VKTX’s current price about 3.32% and -5.77% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 49.68, while 7-day volatility ratio is 4.98% and 9.03% in the 30-day chart. Further, Viking Therapeutics Inc (VKTX) has a beta value of 0.74, and an average true range (ATR) of 2.27. Analysts have given the company’s stock an average 52-week price target of $110, forecast between a low of $74 and high of $110. Looking at the price targets, the low is -146.09% off current price level while to achieve the yearly target high, price needs to move -265.81%. Nonetheless, investors will most likely welcome a -265.81% jump to $110 which is the analysts’ median price.
If we refocus on Viking Therapeutics Inc (NASDAQ:VKTX), historical trading data shows that trading volumes averaged 4.39 over the past 10 days and 4.49 million over the past 3 months. The company’s latest data on shares outstanding shows there are 111.57 million shares.
The 2.94% of Viking Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 73.46% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 23.91 million on 2025-02-28, giving us a short ratio of 4.71. The data shows that as of 2025-02-28 short interest in Viking Therapeutics Inc (VKTX) stood at 2854.0 of shares outstanding, with shares short falling to 23.93 million registered in 2025-01-31. Current price change has pushed the stock -25.27% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the VKTX stock continues to rise going into the next quarter.
